Zhao Weidong, Zhao Xiaohan, Xu Menglin, Cheng Zhengwu, Zhang Zhengxiang
Department of Oncology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.
Department of Gastroenterology, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.
J Oncol. 2022 Nov 8;2022:6228982. doi: 10.1155/2022/6228982. eCollection 2022.
To explore the functional and molecular mechanism of long noncoding RNA LINC01279 in gastric cancer (GC).
The LINC01279 expression in GC and tissues of para-carcinoma was detected by qPCR (real-time fluorescent quantitative PCR), and the association between the LINC01279 expression and clinicopathological features of patients with GC was investigated. The colony formation, CCK-8, transwell assays, and cell cycle detection kit were used for detection of the effect of LINC01279 on GC cell proliferation, cell cycle, colony formation, and invasion. The effect of LINC01279 on PI3K/AKT/mTOR in the GC signaling pathway was identified by the Western blotting technique. The effect of LINC01279 on GC cell proliferation in vivo was evaluated by subcutaneous xenograft tumors in the nude mice.
The results of qPCR displayed the expression of LINC01279 was higher in tissues of GC patients. Furthermore, the tumor size, TNM stage, and metastasis of lymph nodes were also closely related to LINC01279 expression. The experiments on cell function showed that the LINC01279 knockdown significantly inhibited the colony formation, invasion, and proliferation of GC cells and induced the cell cycle arrest in G0 and G1 phases. The Western blotting technique also showed that LINC01279 knockdown significantly inhibited the phosphorylation of PI3K, Akt, and mTOR in GC cells. Furthermore, in vivo experiments displayed that the LINC01279 knockdown significantly inhibited the GC growth.
Knockdown of LINC01279 plays a significant role in inhibiting the PI3K/AKT/mTOR signaling pathway which affects the GC invasion and proliferation. The LINC01279 expression can be utilized as a biomarker for the prediction of the GC prognosis.
探讨长链非编码RNA LINC01279在胃癌(GC)中的功能及分子机制。
采用qPCR(实时荧光定量PCR)检测LINC01279在GC组织及癌旁组织中的表达,并研究LINC01279表达与GC患者临床病理特征之间的关系。使用集落形成实验、CCK-8实验、Transwell实验及细胞周期检测试剂盒检测LINC01279对GC细胞增殖、细胞周期、集落形成及侵袭的影响。通过蛋白质免疫印迹技术鉴定LINC01279对GC信号通路中PI3K/AKT/mTOR的影响。通过裸鼠皮下异种移植瘤评估LINC01279对GC细胞体内增殖的影响。
qPCR结果显示,GC患者组织中LINC01279表达较高。此外,肿瘤大小、TNM分期及淋巴结转移也与LINC01279表达密切相关。细胞功能实验表明,敲低LINC01279可显著抑制GC细胞的集落形成、侵袭及增殖,并诱导细胞周期停滞在G0和G1期。蛋白质免疫印迹技术还显示,敲低LINC01279可显著抑制GC细胞中PI3K、Akt及mTOR的磷酸化。此外,体内实验显示,敲低LINC01279可显著抑制GC生长。
敲低LINC01279在抑制PI3K/AKT/mTOR信号通路中起重要作用,该信号通路影响GC的侵袭和增殖。LINC01279表达可作为预测GC预后的生物标志物。